Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The facility forms a key component of the company’s $23bn US investment programm...
GDP Self-Inspections MVS Pharma GmbH overview: Self-inspections are a cornerston...
Fish oil cardiovascular concerns 2025 overview: Omega-3 fatty acids—particularly...
How does IGMPI’s training ecosystem directly address the root causes of patient...
Syngene International, an integrated research, development and manufacturing se...
Agamree is a new drug that operates by attaching to the same receptor as glucoco...
Through this partnership, Takeda aims to enhance patient care while exploring ne...
Anil Matai, Director General, OPPI: “As India approaches the upcoming Union Bud...
What motivated you to write Quality Trailblazer, and how does it address the mo...
The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit...
Recently, the Indian Ministry of Health and Family Welfare issued a government ...
Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has rece...
The approval offers healthcare providers with an additional option alongside the...
The tender offer expired on 5 January 2026. The transaction involved purchasing ...
Sharp Sterile Manufacturing has announced a $28 million expansion of its site i...
Supriya Lifescience has built a strong global presence in Active Pharmaceutical...
